Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Silexion Therapeutics LTD

    NASDAQ: SLXN · Real-Time Price · USD
    0.81
    -0.03 (-3.78%)
    At close: Jun 17, 2025, 3:58 PM
    0.81
    -0.74%
    Pre-market: Jun 18, 2025, 04:54 AM EDT

    Silexion Therapeutics LTD Statistics

    Share Statistics

    Silexion Therapeutics LTD has 8.69M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 8.69M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,830

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 929.78K, so 10.7% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 929.78K

    Short % of Shares Out

    n/a
    		 10.7%

    Short % of Float

    n/a
    		 11.32%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 0.08 and the forward PE ratio is -0.78. Silexion Therapeutics LTD's PEG ratio is 0.

    PE Ratio

    n/a
    		 0.08

    Forward PE

    n/a
    		 -0.78

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.31

    P/FCF Ratio

    n/a
    		 -0.15

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Silexion Therapeutics LTD.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.64, with a Debt / Equity ratio of -1.13.

    Current Ratio

    n/a
    		 0.64

    Quick Ratio

    n/a
    		 0.64

    Debt / Equity

    n/a
    		 -1.13

    Debt / EBITDA

    n/a
    		 -0.27

    Debt / FCF

    n/a
    		 -0.53

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $1,500,818.18

    Employee Count

    n/a
    		 11

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 10K

    Effective Tax Rate

    n/a
    		 0.06%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.12, so Silexion Therapeutics LTD's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.12

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.91

    200-Day Moving Average

    n/a
    		 2.48

    Relative Strength Index (RSI)

    n/a
    		 34.37

    Average Volume (20 Days)

    n/a
    		 1,639,657

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -12.57M

    Net Income

    n/a
    		 16.51M

    EBITDA

    n/a
    		 -16.43M

    EBIT

    n/a
    		 -16.46M

    Earnings Per Share (EPS)

    n/a
    		 2.03
    Full Income Statement

    Balance Sheet

    The company has 1.19M in cash and 4.49M in debt, giving a net cash position of -3.3M.

    Cash & Cash Equivalents

    n/a
    		 1.19M

    Total Debt

    n/a
    		 4.49M

    Net Cash

    n/a
    		 -3.3M

    Retained Earnings

    n/a
    		 -43.25M

    Total Assets

    n/a
    		 8.31M

    Working Capital

    n/a
    		 5.33M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -8.4M and capital expenditures -22K, giving a free cash flow of -8.42M.

    Operating Cash Flow

    n/a
    		 -8.4M

    Capital Expenditures

    n/a
    		 -22K

    Free Cash Flow

    n/a
    		 -8.42M

    FCF Per Share

    n/a
    		 -13.49
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SLXN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SLXN is $5, which is 517.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 517.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 29, 2024. It was a backward split with a ratio of 1:9.

    Last Split Date

    n/a
    		 Nov 29, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:9

    Scores

    Altman Z-Score

    n/a
    		 -10.4

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist